Platelet Drugs and Antocoagulants

Antiplatelet drugs decrease platelet aggregation and inhibit thrombus formation while anticoagulants are blood thinners that prolong clotting time. Both agents are amongst the most commonly used medications to reduce coagulation.

August 12, 2020

Prescription of oral anticoagulants and antiplatelets for stroke prophylaxis in atrial fibrillation: nationwide time series ecological analysis

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
Jianhua WuChris P Gale
August 12, 2020
Open Access

Thrombolysis and use of argatroban for the treatment of massive pulmonary embolism following anticoagulation failure in a patient with COVID-19

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Lisa M Sagardia, Lisa M Daniels
August 14, 2020

Antithrombin III-mediated blood coagulation inhibitory activity of chitosan sulfate derivatized with different functional groups

International Journal of Biological Macromolecules
Pathum ChandikaWon-Kyo Jung
August 12, 2020

Clinical characteristics and outcomes of COMPASS eligible patients in France. An analysis from the REACH Registry

Annales de cardiologie et d'angéiologie
A DarmonP G Steg
August 12, 2020

Author's Reply to Vaz et al.: "Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease"

American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
Yonghui FuWenfeng He
August 12, 2020
Open Access

Development of pulmonary embolism in a nonhospitalized patient with COVID-19 who did not receive venous thromboembolism prophylaxis

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Ellen M Uppuluri, Nancy L Shapiro
August 14, 2020

Rationale, design and methodology of TESEO study: a registry of thrombosis and neoplasia of SEOM (Spanish Society of Medical Oncology)

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
J Muñoz-LangaA Muñoz-Martín
August 13, 2020
Open Access

Increase of Neutrophil Activation Markers in Venous Thrombosis-Contribution of Circulating Activated Protein C

International Journal of Molecular Sciences
Laura MartosPilar Medina
August 12, 2020

Chemical O-sulfation of N-sulfoheparosan: a route to rare N-sulfo-3-O-sulfoglucosamine and 2-O-sulfoglucuronic acid

Glycoconjugate Journal
Lufeng YanRobert J Linhardt
August 12, 2020

Propensity-matched comparison of antiplatelet vs. anticoagulant after left atrial appendage closure with the Watchman

Pacing and Clinical Electrophysiology : PACE
Xiao-Xia LiuChangsheng Ma
August 14, 2020
Open Access

The use and adherence of oral anticoagulants in Primary Health Care in Catalunya, Spain: A real-world data cohort study

Atencion primaria
Maria Giner-SorianoRosa Morros
August 14, 2020

Patients experience of living with cancer associated thrombosis in France (Le PELICAN)

Thrombosis Research
Isabelle MahéSimon Noble
August 12, 2020
Open Access

Comment on: Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease

American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
Igor VazRajkumar Doshi
August 13, 2020
Review
Open Access

Treatment of deep vein thrombosis of the lower extremities

Revista clínica española
A J Trujillo Santos
August 14, 2020

Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: One year follow up of the prospective observational ETNA-AF-Europe study

European Heart Journal. Cardiovascular Pharmacotherapy
J R de GrootETNA-AF-Europe investigators

Sign up to follow this feed and discover related papers.

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Coagulation Products

Coagulation products used to manage bleeding in patients with these disorders include AHF concentrates, factor IX concentrates, factor VIIa concentrate, factor IX complexes, anti-inhibitor coagulant complexes, and desmopressin acetate. Discover the latest research on coagulation products here.

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.

Immuno-Oncology

Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.

Immunomodulating Agents

Immunomodulating agents are substances that stimulate or suppresse the immune system and may help the body combat againsts cancer, infection, or other diseases. Discover the latest research on immunomodulating agents here.

Metastatic Malignancy Treatments

Treatment of metastatic cancers depends on the type of cancer and the severity of the disease. The regime often includes medications such as chemotherapy or hormone therapy, but may also include immunotherapy, radiation therapy, surgery or a combination. Discover the latest research on metastatic cancer treatments here.

Pharmacological Treatment of Allergies

Allergies, also known as allergic diseases, are a number of conditions caused by hypersensitivity of the immune system to typically harmless substances in the environment. There are various pharmacological treatments for allergy including antihistamines, anti-cholinergics, decongestants, etc. Discover the latest research on pharmacological treatment of allergies here.

© 2020 Meta ULC. All rights reserved
/feed-previews/platelet-drugs-and-antocoagulants/a25cc4bc-cd2b-403b-a944-87c879181e1b